Pharvaris Management
Management criteria checks 3/4
Pharvaris' CEO is Berndt Axel Modig, appointed in Sep 2015, has a tenure of 10.25 years. total yearly compensation is €580.86K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 2.28% of the company’s shares, worth $38.22M. The average tenure of the management team and the board of directors is 5.1 years and 4.9 years respectively.
Key information
Berndt Axel Modig
Chief executive officer
€580.9k
Total compensation
| CEO salary percentage | 100.00% |
| CEO tenure | 10.3yrs |
| CEO ownership | 2.3% |
| Management average tenure | 5.1yrs |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
Pharvaris: Biotech With De-Risked Phase 3 Readout Coming, Initiating With A Buy Rating
Nov 23Here's Why We're Watching Pharvaris' (NASDAQ:PHVS) Cash Burn Situation
Jul 05
We're Hopeful That Pharvaris (NASDAQ:PHVS) Will Use Its Cash Wisely
Mar 17Pharvaris: Despite 30% Decline, Still Fair At Best
Dec 29Here's Why We're Not Too Worried About Pharvaris' (NASDAQ:PHVS) Cash Burn Situation
Dec 02We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth
Aug 16Pharvaris: Digging Deep For Sufficient Market Size
Jan 17We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth
Oct 09Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
May 13Companies Like Pharvaris (NASDAQ:PHVS) Are In A Position To Invest In Growth
Jan 11We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth
Sep 26Pharvaris GAAP EPS of -€0.38
Sep 12Pharvaris slips 19% after FDA clinical hold on hereditary angioedema candidate
Aug 22We're Not Very Worried About Pharvaris' (NASDAQ:PHVS) Cash Burn Rate
Jun 08Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
Dec 21We're Not Very Worried About Pharvaris' (NASDAQ:PHVS) Cash Burn Rate
Aug 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -€164m |
| Jun 30 2025 | n/a | n/a | -€168m |
| Mar 31 2025 | n/a | n/a | -€153m |
| Dec 31 2024 | €581k | €581k | -€134m |
| Sep 30 2024 | n/a | n/a | -€132m |
| Jun 30 2024 | n/a | n/a | -€114m |
| Mar 31 2024 | n/a | n/a | -€106m |
| Dec 31 2023 | €532k | €532k | -€101m |
| Sep 30 2023 | n/a | n/a | -€107m |
| Jun 30 2023 | n/a | n/a | -€92m |
| Mar 31 2023 | n/a | n/a | -€83m |
| Dec 31 2022 | €500k | €500k | -€76m |
| Sep 30 2022 | n/a | n/a | -€49m |
| Jun 30 2022 | n/a | n/a | -€50m |
| Mar 31 2022 | n/a | n/a | -€53m |
| Dec 31 2021 | €414k | €414k | -€43m |
| Sep 30 2021 | n/a | n/a | -€41m |
| Jun 30 2021 | n/a | n/a | -€38m |
| Mar 31 2021 | n/a | n/a | -€29m |
| Dec 31 2020 | €404k | €404k | -€26m |
Compensation vs Market: Berndt Axel's total compensation ($USD684.81K) is below average for companies of similar size in the US market ($USD5.43M).
Compensation vs Earnings: Berndt Axel's compensation has increased whilst the company is unprofitable.
CEO
Berndt Axel Modig (66 yo)
Mr. Berndt Axel Edvard Modig, MBA, CPA, serves as Chief Executive Officer since 2015 and Executive Director of Pharvaris B.V. Mr. Modig served as a Member of the Supervisory Board at Centogene N.V. since A...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 10.3yrs | €580.86k | 2.28% $ 38.2m | |
| CFO, Chief Legal Officer & Corporate Secretary | 1.7yrs | no data | 0.0012% $ 20.7k | |
| Head of Strategic Finance & Principal Accounting Officer | 5.9yrs | no data | 0.078% $ 1.3m | |
| Chief Technology Operations Officer | 2.1yrs | no data | 0.052% $ 872.5k | |
| Chief Human Resources Officer | 3.3yrs | no data | 0.088% $ 1.5m | |
| Chief Medical Officer | 5.8yrs | no data | 0.73% $ 12.2m | |
| Chief Early Development Officer | 10.9yrs | no data | 0.61% $ 10.2m | |
| Chief Commercial Officer | 4.4yrs | no data | 0.29% $ 4.9m | |
| Director of Corporate Relations | no data | no data | no data |
Experienced Management: PHVS's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | no data | €580.86k | 2.28% $ 38.2m | |
| Independent Non-Executive Director | 4.9yrs | €53.09k | 0.096% $ 1.6m | |
| Independent Non-Executive Chair | 4.9yrs | €90.74k | 0.16% $ 2.7m | |
| Independent Vice Chairman | 6.3yrs | €58.88k | 0.70% $ 11.8m | |
| Non-Executive Director | 4yrs | €43.44k | 0.078% $ 1.3m | |
| Non-Executive Director | 4.4yrs | €62.74k | 0.085% $ 1.4m |
Experienced Board: PHVS's board of directors are considered experienced (4.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/24 09:53 |
| End of Day Share Price | 2025/12/23 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pharvaris N.V. is covered by 14 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tazeen Ahmad | BofA Global Research |
| Steven Seedhouse | Cantor Fitzgerald & Co. |
| Jonathan Wolleben | Citizens JMP Securities, LLC |